4 unknown, 1 terminated. 5 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Unknown 4, Terminated 1 |
| Phase 2 | 1 | Unknown 1 |
Follow TQB2618 injection: new trials by email Literature Review of TQB2618 injection trials Research Report on TQB2618 injection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Study of TQB2618 Injection Monotherapy and Combination Regimen (With Penpulimab Injection ±Anlotinib Hydrochloride Capsules) in the Four or Later Lines of Treatment of Advanced Colorectal Cancer. TQB2618 injection, Penpulimab injection, Anlotinib hydrochloride capsules - Colorectal Cancer | Phase 1 | Unknown | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 75 | 2024-01-13 | 2024-01-23 |
| A Clinical Study of TQB2618 Injection Combined With Penpulimab Injection and Anlotinib Hydrochloride Capsules for First-line Treatment of Advanced Hepatocellular Carcinoma (HCC). Penpulimab injection, TQB2618 injection, Anlotinib Hydrochloride Capsules - Advanced Hepatocellular Carcinoma | Phase 1 | Terminated | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 29 | 2023-08-15 | 2025-08-12 |
| Efficacy and Safety of TQB2618 Injection Combined With Toripalimab Injection in Patients With Advanced Melanoma TQB2618 injection, Toripalimab injection - Melanoma | Phase 1 | Unknown | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 50 | 2022-08-09 | 2023-07-07 |
| To Evaluate the Safety and Efficacy of TQB2618 Injection Combined With Penpulimab in the Treatment of Patients With Relapsed and Refractory Lymphoma TQB2618 injection, Penpulimab injection - Relapsed/Refractory Lymphoma | Phase 1 / Phase 2 | Unknown | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 92 | 2022-06-09 | 2023-02-14 |
| A Study to Evaluate the Tolerance and Pharmacokinetics of TQB2618 Injection in Subjects With Advanced Solid Tumors TQB2618 injection - Advanced Solid Tumors | Phase 1 | Unknown | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 50 | 2020-12-01 | 2020-11-10 |
Colorectal Neoplasms (1) · Lymphoma (1) · Melanoma (1)
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (5)
China (5)